Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates.

ABSTRACT:

Objectives

To systematically review the literature pertaining to the prevalence of depression and anxiety in patients with prostate cancer as a function of treatment stage.

Design

Systematic review and meta-analysis.

Participants

4494 patients with prostate cancer from primary research investigations.

Primary outcome measure

The prevalence of clinical depression and anxiety in patients with prostate cancer as a function of treatment stage.

Results

We identified 27 full journal articles that met the inclusion criteria for entry into the meta-analysis resulting in a pooled sample size of 4494 patients. The meta-analysis of prevalence rates identified pretreatment, on-treatment and post-treatment depression prevalences of 17.27% (95% CI 15.06% to 19.72%), 1

SUBMITTER: Watts S 

PROVIDER: S-EPMC3963074 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature